Business Deal

Unsealed court documents reveal how drug companies ramped up sales during the epidemic.

Analysts say the terms from a global settlement around opioids will impact shares in the future

Drug industry and ravaged communities seek an opioids deal. That won’t come easy — or end the crisis.

Following a major settlement in Ohio this week, California counties could be a step closer to getting the drug industry to pay for damages associated with the opioid epidemic.

Four companies cited in a lawsuit from counties in Ohio seeking to place blame for the ongoing opioid epidemic have settled the so-called bellwether case for a total of $265 million, attorney Hunter Shkolnik, who represents the counties, told S&P Global Market Intelligence.

First federal trial on U.S. opioid crisis is to focus on how powerful prescription painkillers were distributed.

West Union, Ohio — Four major drug companies reached a last-minute settlement Monday, avoiding the first federal trial in the opioid epidemic. The companies, McKesson, Cardinal Health, AmerisourceBergen and Teva Pharmaceutical, reached a settlement totaling $260 million with two counties in Ohio.

Ohio Gov. Mike DeWine said Tuesday that he has convened a meeting with the state attorney general and lawyers for cities and counties involved in the national opioid litigation to discuss how millions in settlement dollars might be spent.